GR870195B - Vaccines against melanoma - Google Patents

Vaccines against melanoma

Info

Publication number
GR870195B
GR870195B GR870195A GR870100195A GR870195B GR 870195 B GR870195 B GR 870195B GR 870195 A GR870195 A GR 870195A GR 870100195 A GR870100195 A GR 870100195A GR 870195 B GR870195 B GR 870195B
Authority
GR
Greece
Prior art keywords
vaccines against
against melanoma
melanoma
vaccines
Prior art date
Application number
GR870195A
Other languages
Greek (el)
English (en)
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR870195(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of GR870195B publication Critical patent/GR870195B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GR870195A 1986-02-07 1987-02-06 Vaccines against melanoma GR870195B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (1)

Publication Number Publication Date
GR870195B true GR870195B (en) 1987-06-10

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
GR870195A GR870195B (en) 1986-02-07 1987-02-06 Vaccines against melanoma

Country Status (18)

Country Link
JP (3) JP2664673B2 (de)
BE (1) BE1000175A3 (de)
CH (1) CH675424A5 (de)
DE (1) DE3703702C2 (de)
DK (1) DK63287A (de)
ES (2) ES2012815A6 (de)
FI (1) FI94836C (de)
GR (1) GR870195B (de)
HU (1) HU209144B (de)
IE (1) IE59597B1 (de)
IT (1) IT1222359B (de)
MX (1) MX9203574A (de)
NL (1) NL8700285A (de)
NO (1) NO178931C (de)
NZ (1) NZ219192A (de)
OA (1) OA08478A (de)
PT (1) PT84255B (de)
SE (2) SE506024C2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
FI870501A (fi) 1987-08-08
IE59597B1 (en) 1994-03-09
SE8700466D0 (sv) 1987-02-06
HUT43107A (en) 1987-09-28
HU209144B (en) 1994-03-28
DK63287A (da) 1987-08-08
FI94836B (fi) 1995-07-31
IE870319L (en) 1987-08-07
JP2664673B2 (ja) 1997-10-15
IT8719291A0 (it) 1987-02-06
NZ219192A (en) 1991-10-25
DK63287D0 (da) 1987-02-06
FI94836C (fi) 1995-11-10
NO178931C (no) 1996-07-03
JPH09135692A (ja) 1997-05-27
NL8700285A (nl) 1987-09-01
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
BE1000175A3 (fr) 1988-07-12
DE3703702C2 (de) 1997-07-10
JPH08280390A (ja) 1996-10-29
CH675424A5 (en) 1990-09-28
OA08478A (fr) 1988-07-29
PT84255A (en) 1987-03-01
IT1222359B (it) 1990-09-05
NO178931B (no) 1996-03-25
NO870475L (no) 1987-08-10
FI870501A0 (fi) 1987-02-06
NO870475D0 (no) 1987-02-06
ES2017258A6 (es) 1991-01-16
ES2012815A6 (es) 1990-04-16
JPS62294698A (ja) 1987-12-22
DE3703702A1 (de) 1988-02-18
SE8700466L (sv) 1987-08-08
SE9202934D0 (sv) 1992-10-07
MX9203574A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
IL81481A0 (en) Vaccines against melanoma
EP0256878A3 (en) Vaccines
GB2188637B (en) Vaccines against melanoma
GB8606707D0 (en) Combination feedboat
ZA872532B (en) Combined vaccine
ZW22487A1 (en) Vaccine
GB8721453D0 (en) Ice-combative measures
GB8619098D0 (en) Combination
ZA874847B (en) Oncornavirus vaccines
GR870195B (en) Vaccines against melanoma
GB8610557D0 (en) Retaining means
GB8615068D0 (en) Vaccines
GB8715304D0 (en) Retaining member
GB2194684B (en) Securing objects
PL264544A1 (en) Expresso
GB8605646D0 (en) Vaccines
GB2184937B (en) Coffee-maker
GB8606560D0 (en) Vaccines
GB8620059D0 (en) Vaccines
GB8629475D0 (en) Vaccines
GB8606559D0 (en) Vaccines
GB8604743D0 (en) Vaccines
GB8629988D0 (en) Vaccines
GB8708872D0 (en) Retaining means
GB8619602D0 (en) Vaccine